Skip to content
The People's CodeSearch
Menu

Changes to the Code

S. 977 · End Taxpayer Funding of Gender Experimentation Act of 2025 ·

In committee · step 2 of 5

Sections are cited like “7 U.S.C. § 2012”: 7 of the , 2012.

1 U.S.C. § 301 Prohibition on funding for gender transition procedures New section

+2 −0Shown
More for 1 U.S.C. § 301
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Title 1, United States Code, is amended by adding at the end the following new chapter:4 Prohibiting taxpayer-funded gender transition procedures 301. Prohibition on funding for gender transition procedures No funds authorized or appropriated by Federal law, and none of the funds in any trust fund to which funds are authorized or appropriated by Federal law, shall be expended for any gender transition procedures. 302. Prohibition on funding for health benefits plans that cover gender transition procedures No funds authorized or appropriated by Federal law, and none of the funds in any trust fund to which funds are authorized or appropriated by Federal law, shall be expended for health benefits coverage that includes coverage of gender transition procedures. 303. Limitation on Federal facilities and employees No health care service furnished— (1) by or in a health care facility owned or operated by the Federal Government; or (2) by any physician or other individual employed by the Federal Government to provide health care services within the scope of the physician’s or individual’s employment, may include gender transition procedures. 304. Construction relating to separate coverage Nothing in this chapter shall be construed as prohibiting any individual, entity, or State or locality from purchasing separate coverage for gender transition procedures or health benefits coverage that includes gender transition procedures so long as such coverage is paid for entirely using only funds not authorized or appropriated by Federal law and such coverage shall not be purchased using matching funds required for a federally subsidized program, including a State’s or locality’s contribution of Medicaid matching funds. 305. Construction relating to the use of non-Federal funds for health coverage Nothing in this chapter shall be construed as restricting the ability of any non-Federal health benefits coverage provider from offering coverage for gender transition procedures, or the ability of a State or locality to contract separately with such a provider for such coverage, so long as only funds not authorized or appropriated by Federal law are used and such coverage shall not be purchased using matching funds required for a federally subsidized program, including a State’s or locality’s contribution of Medicaid matching funds. 306. Construction relating to complications arising from gender transition procedures Nothing in this chapter shall be construed to apply to the treatment of any infection, injury, disease, or disorder that has been caused by or exacerbated by the performance of a gender transition procedure. 307. Definitions For purposes of this chapter: (1) Female.— The term female, when used to refer to a natural person, means an individual who naturally has, had, will have, or would have, but for a congenital anomaly, historical accident, or intentional or unintentional disruption, the reproductive system that at some point produces, transports, and utilizes eggs for fertilization. (2) Gender transition.— The term gender transition means the process in which an individual goes from identifying with or presenting as his or her sex to identifying with or presenting a self-proclaimed identity that does not correspond with or is different from his or her sex, and may be accompanied with social, legal, or physical changes. (3) Gender transition procedure.— (A) In general.— The term gender transition procedure means any hormonal or surgical intervention for the purpose of gender transition, including— (i) gonadotropin-releasing hormone (GnRH) agonists or other puberty-blocking or suppressing drugs to stop or delay normal puberty; (ii) testosterone, estrogen, progesterone, or other androgens to an individual at doses that are supraphysiologic to what would normally be produced endogenously in a healthy individual of the same age and sex; (iii) castration; (iv) orchiectomy; (v) scrotoplasty; (vi) implantation of erection or testicular prostheses; (vii) vasectomy; (viii) hysterectomy; (ix) oophorectomy; (x) ovariectomy; (xi) reconstruction of the fixed part of the urethra with or without a metoidioplasty or a phalloplasty; (xii) metoidioplasty; (xiii) penectomy; (xiv) phalloplasty; (xv) vaginoplasty; (xvi) clitoroplasty (xvii) vaginectomy; (xviii) vulvoplasty; (xix) reduction thyrochondroplasty; (xx) chondrolaryngoplasty; (xxi) mastectomy; (xxii) tubal ligation; (xxiii) sterilization; (xxiv) any plastic, cosmetic, or aesthetic surgery that feminizes or masculinizes the facial or other physiological features of an individual; (xxv) any placement of chest implants to create feminine breasts; (xxvi) any placement of fat or artificial implants in the gluteal region; (xxvii) augmentation mammoplasty; (xxviii) liposuction; (xxix) lipofilling; (xxx) voice surgery; (xxxi) hair reconstruction; (xxxii) pectoral implants; and (xxxiii) the removal of any otherwise healthy or non-diseased body part or tissue. (B) Exclusions.— The term gender transition procedure does not include the following when furnished to an individual by a health care provider with the consent of such individual or, if applicable, such individual’s parents or legal guardian: (i) Services to individuals born with a medically verifiable disorder of sex development, including an individual with external sex characteristics that are irresolvably ambiguous, such as an individual born with 46 XX chromosomes with virilization, an individual born with 46 XY chromosomes with undervirilization, or an individual born having both ovarian and testicular tissue. (ii) Services provided when a physician has otherwise diagnosed a disorder of sexual development in which the physician has determined through genetic or biochemical testing that the individual does not have normal sex chromosome structure, sex steroid hormone production, or sex steroid hormone action for a healthy individual of the same sex and age. (iii) The treatment of any infection, injury, disease, or disorder that has been caused by or exacerbated by the performance of gender transition procedures, whether or not the gender transition procedure was performed in accordance with State and Federal law or whether or not funding for the gender transition procedure is permissible under this section. (iv) Any procedure undertaken because the individual suffers from a physical disorder, physical injury, or physical illness (but not mental, behavioral, or emotional distress or a mental, behavioral, or emotional disorder) that would, as certified by a physician, place the individual in imminent danger of death or impairment of major bodily function, unless the procedure is performed. (v) Puberty suppression or blocking prescription drugs for the purpose of normalizing puberty for a minor experiencing precocious puberty. (vi) Male circumcision. (4) Male.— The term male, when used to refer to a natural person, means an individual who naturally has, had, will have, or would have, but for a congenital anomaly, historical accident, or intentional or unintentional disruption, the reproductive system that at some point produces, transports, and utilizes sperm for fertilization. (5) Sex.— The term sex, when referring to an individual’s sex, means to refer to either male or female, as biologically determined..

§ 301

WhereMarkThe Code nowMarkAs the bill would leave it
§ 301. [inserted: Prohibition on funding for gender transition procedures]
[inserted: No funds authorized or appropriated by Federal law, and none of the funds in any trust fund to which funds are authorized or appropriated by Federal law, shall be expended for any gender transition procedures.]

1 U.S.C. § 302 Prohibition on funding for health benefits plans that cover gender transition procedures New section

+2 −0Shown
More for 1 U.S.C. § 302
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Title 1, United States Code, is amended by adding at the end the following new chapter:4 Prohibiting taxpayer-funded gender transition procedures 301. Prohibition on funding for gender transition procedures No funds authorized or appropriated by Federal law, and none of the funds in any trust fund to which funds are authorized or appropriated by Federal law, shall be expended for any gender transition procedures. 302. Prohibition on funding for health benefits plans that cover gender transition procedures No funds authorized or appropriated by Federal law, and none of the funds in any trust fund to which funds are authorized or appropriated by Federal law, shall be expended for health benefits coverage that includes coverage of gender transition procedures. 303. Limitation on Federal facilities and employees No health care service furnished— (1) by or in a health care facility owned or operated by the Federal Government; or (2) by any physician or other individual employed by the Federal Government to provide health care services within the scope of the physician’s or individual’s employment, may include gender transition procedures. 304. Construction relating to separate coverage Nothing in this chapter shall be construed as prohibiting any individual, entity, or State or locality from purchasing separate coverage for gender transition procedures or health benefits coverage that includes gender transition procedures so long as such coverage is paid for entirely using only funds not authorized or appropriated by Federal law and such coverage shall not be purchased using matching funds required for a federally subsidized program, including a State’s or locality’s contribution of Medicaid matching funds. 305. Construction relating to the use of non-Federal funds for health coverage Nothing in this chapter shall be construed as restricting the ability of any non-Federal health benefits coverage provider from offering coverage for gender transition procedures, or the ability of a State or locality to contract separately with such a provider for such coverage, so long as only funds not authorized or appropriated by Federal law are used and such coverage shall not be purchased using matching funds required for a federally subsidized program, including a State’s or locality’s contribution of Medicaid matching funds. 306. Construction relating to complications arising from gender transition procedures Nothing in this chapter shall be construed to apply to the treatment of any infection, injury, disease, or disorder that has been caused by or exacerbated by the performance of a gender transition procedure. 307. Definitions For purposes of this chapter: (1) Female.— The term female, when used to refer to a natural person, means an individual who naturally has, had, will have, or would have, but for a congenital anomaly, historical accident, or intentional or unintentional disruption, the reproductive system that at some point produces, transports, and utilizes eggs for fertilization. (2) Gender transition.— The term gender transition means the process in which an individual goes from identifying with or presenting as his or her sex to identifying with or presenting a self-proclaimed identity that does not correspond with or is different from his or her sex, and may be accompanied with social, legal, or physical changes. (3) Gender transition procedure.— (A) In general.— The term gender transition procedure means any hormonal or surgical intervention for the purpose of gender transition, including— (i) gonadotropin-releasing hormone (GnRH) agonists or other puberty-blocking or suppressing drugs to stop or delay normal puberty; (ii) testosterone, estrogen, progesterone, or other androgens to an individual at doses that are supraphysiologic to what would normally be produced endogenously in a healthy individual of the same age and sex; (iii) castration; (iv) orchiectomy; (v) scrotoplasty; (vi) implantation of erection or testicular prostheses; (vii) vasectomy; (viii) hysterectomy; (ix) oophorectomy; (x) ovariectomy; (xi) reconstruction of the fixed part of the urethra with or without a metoidioplasty or a phalloplasty; (xii) metoidioplasty; (xiii) penectomy; (xiv) phalloplasty; (xv) vaginoplasty; (xvi) clitoroplasty (xvii) vaginectomy; (xviii) vulvoplasty; (xix) reduction thyrochondroplasty; (xx) chondrolaryngoplasty; (xxi) mastectomy; (xxii) tubal ligation; (xxiii) sterilization; (xxiv) any plastic, cosmetic, or aesthetic surgery that feminizes or masculinizes the facial or other physiological features of an individual; (xxv) any placement of chest implants to create feminine breasts; (xxvi) any placement of fat or artificial implants in the gluteal region; (xxvii) augmentation mammoplasty; (xxviii) liposuction; (xxix) lipofilling; (xxx) voice surgery; (xxxi) hair reconstruction; (xxxii) pectoral implants; and (xxxiii) the removal of any otherwise healthy or non-diseased body part or tissue. (B) Exclusions.— The term gender transition procedure does not include the following when furnished to an individual by a health care provider with the consent of such individual or, if applicable, such individual’s parents or legal guardian: (i) Services to individuals born with a medically verifiable disorder of sex development, including an individual with external sex characteristics that are irresolvably ambiguous, such as an individual born with 46 XX chromosomes with virilization, an individual born with 46 XY chromosomes with undervirilization, or an individual born having both ovarian and testicular tissue. (ii) Services provided when a physician has otherwise diagnosed a disorder of sexual development in which the physician has determined through genetic or biochemical testing that the individual does not have normal sex chromosome structure, sex steroid hormone production, or sex steroid hormone action for a healthy individual of the same sex and age. (iii) The treatment of any infection, injury, disease, or disorder that has been caused by or exacerbated by the performance of gender transition procedures, whether or not the gender transition procedure was performed in accordance with State and Federal law or whether or not funding for the gender transition procedure is permissible under this section. (iv) Any procedure undertaken because the individual suffers from a physical disorder, physical injury, or physical illness (but not mental, behavioral, or emotional distress or a mental, behavioral, or emotional disorder) that would, as certified by a physician, place the individual in imminent danger of death or impairment of major bodily function, unless the procedure is performed. (v) Puberty suppression or blocking prescription drugs for the purpose of normalizing puberty for a minor experiencing precocious puberty. (vi) Male circumcision. (4) Male.— The term male, when used to refer to a natural person, means an individual who naturally has, had, will have, or would have, but for a congenital anomaly, historical accident, or intentional or unintentional disruption, the reproductive system that at some point produces, transports, and utilizes sperm for fertilization. (5) Sex.— The term sex, when referring to an individual’s sex, means to refer to either male or female, as biologically determined..

§ 302

WhereMarkThe Code nowMarkAs the bill would leave it
§ 302. [inserted: Prohibition on funding for health benefits plans that cover gender transition procedures]
[inserted: No funds authorized or appropriated by Federal law, and none of the funds in any trust fund to which funds are authorized or appropriated by Federal law, shall be expended for health benefits coverage that includes coverage of gender transition procedures.]

1 U.S.C. § 303 Limitation on Federal facilities and employees New section

+7 −0Shown
More for 1 U.S.C. § 303
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Title 1, United States Code, is amended by adding at the end the following new chapter:4 Prohibiting taxpayer-funded gender transition procedures 301. Prohibition on funding for gender transition procedures No funds authorized or appropriated by Federal law, and none of the funds in any trust fund to which funds are authorized or appropriated by Federal law, shall be expended for any gender transition procedures. 302. Prohibition on funding for health benefits plans that cover gender transition procedures No funds authorized or appropriated by Federal law, and none of the funds in any trust fund to which funds are authorized or appropriated by Federal law, shall be expended for health benefits coverage that includes coverage of gender transition procedures. 303. Limitation on Federal facilities and employees No health care service furnished— (1) by or in a health care facility owned or operated by the Federal Government; or (2) by any physician or other individual employed by the Federal Government to provide health care services within the scope of the physician’s or individual’s employment, may include gender transition procedures. 304. Construction relating to separate coverage Nothing in this chapter shall be construed as prohibiting any individual, entity, or State or locality from purchasing separate coverage for gender transition procedures or health benefits coverage that includes gender transition procedures so long as such coverage is paid for entirely using only funds not authorized or appropriated by Federal law and such coverage shall not be purchased using matching funds required for a federally subsidized program, including a State’s or locality’s contribution of Medicaid matching funds. 305. Construction relating to the use of non-Federal funds for health coverage Nothing in this chapter shall be construed as restricting the ability of any non-Federal health benefits coverage provider from offering coverage for gender transition procedures, or the ability of a State or locality to contract separately with such a provider for such coverage, so long as only funds not authorized or appropriated by Federal law are used and such coverage shall not be purchased using matching funds required for a federally subsidized program, including a State’s or locality’s contribution of Medicaid matching funds. 306. Construction relating to complications arising from gender transition procedures Nothing in this chapter shall be construed to apply to the treatment of any infection, injury, disease, or disorder that has been caused by or exacerbated by the performance of a gender transition procedure. 307. Definitions For purposes of this chapter: (1) Female.— The term female, when used to refer to a natural person, means an individual who naturally has, had, will have, or would have, but for a congenital anomaly, historical accident, or intentional or unintentional disruption, the reproductive system that at some point produces, transports, and utilizes eggs for fertilization. (2) Gender transition.— The term gender transition means the process in which an individual goes from identifying with or presenting as his or her sex to identifying with or presenting a self-proclaimed identity that does not correspond with or is different from his or her sex, and may be accompanied with social, legal, or physical changes. (3) Gender transition procedure.— (A) In general.— The term gender transition procedure means any hormonal or surgical intervention for the purpose of gender transition, including— (i) gonadotropin-releasing hormone (GnRH) agonists or other puberty-blocking or suppressing drugs to stop or delay normal puberty; (ii) testosterone, estrogen, progesterone, or other androgens to an individual at doses that are supraphysiologic to what would normally be produced endogenously in a healthy individual of the same age and sex; (iii) castration; (iv) orchiectomy; (v) scrotoplasty; (vi) implantation of erection or testicular prostheses; (vii) vasectomy; (viii) hysterectomy; (ix) oophorectomy; (x) ovariectomy; (xi) reconstruction of the fixed part of the urethra with or without a metoidioplasty or a phalloplasty; (xii) metoidioplasty; (xiii) penectomy; (xiv) phalloplasty; (xv) vaginoplasty; (xvi) clitoroplasty (xvii) vaginectomy; (xviii) vulvoplasty; (xix) reduction thyrochondroplasty; (xx) chondrolaryngoplasty; (xxi) mastectomy; (xxii) tubal ligation; (xxiii) sterilization; (xxiv) any plastic, cosmetic, or aesthetic surgery that feminizes or masculinizes the facial or other physiological features of an individual; (xxv) any placement of chest implants to create feminine breasts; (xxvi) any placement of fat or artificial implants in the gluteal region; (xxvii) augmentation mammoplasty; (xxviii) liposuction; (xxix) lipofilling; (xxx) voice surgery; (xxxi) hair reconstruction; (xxxii) pectoral implants; and (xxxiii) the removal of any otherwise healthy or non-diseased body part or tissue. (B) Exclusions.— The term gender transition procedure does not include the following when furnished to an individual by a health care provider with the consent of such individual or, if applicable, such individual’s parents or legal guardian: (i) Services to individuals born with a medically verifiable disorder of sex development, including an individual with external sex characteristics that are irresolvably ambiguous, such as an individual born with 46 XX chromosomes with virilization, an individual born with 46 XY chromosomes with undervirilization, or an individual born having both ovarian and testicular tissue. (ii) Services provided when a physician has otherwise diagnosed a disorder of sexual development in which the physician has determined through genetic or biochemical testing that the individual does not have normal sex chromosome structure, sex steroid hormone production, or sex steroid hormone action for a healthy individual of the same sex and age. (iii) The treatment of any infection, injury, disease, or disorder that has been caused by or exacerbated by the performance of gender transition procedures, whether or not the gender transition procedure was performed in accordance with State and Federal law or whether or not funding for the gender transition procedure is permissible under this section. (iv) Any procedure undertaken because the individual suffers from a physical disorder, physical injury, or physical illness (but not mental, behavioral, or emotional distress or a mental, behavioral, or emotional disorder) that would, as certified by a physician, place the individual in imminent danger of death or impairment of major bodily function, unless the procedure is performed. (v) Puberty suppression or blocking prescription drugs for the purpose of normalizing puberty for a minor experiencing precocious puberty. (vi) Male circumcision. (4) Male.— The term male, when used to refer to a natural person, means an individual who naturally has, had, will have, or would have, but for a congenital anomaly, historical accident, or intentional or unintentional disruption, the reproductive system that at some point produces, transports, and utilizes sperm for fertilization. (5) Sex.— The term sex, when referring to an individual’s sex, means to refer to either male or female, as biologically determined..

§ 303(1)–(2)

WhereMarkThe Code nowMarkAs the bill would leave it
§ 303. [inserted: Limitation on Federal facilities and employees]
[inserted: No health care service furnished—]
(1)(1) [inserted: ]
[inserted: by or in a health care facility owned or operated by the Federal Government; or]
(2)(2) [inserted: ]
[inserted: by any physician or other individual employed by the Federal Government to provide health care services within the scope of the physician’s or individual’s employment,]
[inserted: may include gender transition procedures.]

1 U.S.C. § 304 Construction relating to separate coverage New section

+2 −0Shown
More for 1 U.S.C. § 304
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Title 1, United States Code, is amended by adding at the end the following new chapter:4 Prohibiting taxpayer-funded gender transition procedures 301. Prohibition on funding for gender transition procedures No funds authorized or appropriated by Federal law, and none of the funds in any trust fund to which funds are authorized or appropriated by Federal law, shall be expended for any gender transition procedures. 302. Prohibition on funding for health benefits plans that cover gender transition procedures No funds authorized or appropriated by Federal law, and none of the funds in any trust fund to which funds are authorized or appropriated by Federal law, shall be expended for health benefits coverage that includes coverage of gender transition procedures. 303. Limitation on Federal facilities and employees No health care service furnished— (1) by or in a health care facility owned or operated by the Federal Government; or (2) by any physician or other individual employed by the Federal Government to provide health care services within the scope of the physician’s or individual’s employment, may include gender transition procedures. 304. Construction relating to separate coverage Nothing in this chapter shall be construed as prohibiting any individual, entity, or State or locality from purchasing separate coverage for gender transition procedures or health benefits coverage that includes gender transition procedures so long as such coverage is paid for entirely using only funds not authorized or appropriated by Federal law and such coverage shall not be purchased using matching funds required for a federally subsidized program, including a State’s or locality’s contribution of Medicaid matching funds. 305. Construction relating to the use of non-Federal funds for health coverage Nothing in this chapter shall be construed as restricting the ability of any non-Federal health benefits coverage provider from offering coverage for gender transition procedures, or the ability of a State or locality to contract separately with such a provider for such coverage, so long as only funds not authorized or appropriated by Federal law are used and such coverage shall not be purchased using matching funds required for a federally subsidized program, including a State’s or locality’s contribution of Medicaid matching funds. 306. Construction relating to complications arising from gender transition procedures Nothing in this chapter shall be construed to apply to the treatment of any infection, injury, disease, or disorder that has been caused by or exacerbated by the performance of a gender transition procedure. 307. Definitions For purposes of this chapter: (1) Female.— The term female, when used to refer to a natural person, means an individual who naturally has, had, will have, or would have, but for a congenital anomaly, historical accident, or intentional or unintentional disruption, the reproductive system that at some point produces, transports, and utilizes eggs for fertilization. (2) Gender transition.— The term gender transition means the process in which an individual goes from identifying with or presenting as his or her sex to identifying with or presenting a self-proclaimed identity that does not correspond with or is different from his or her sex, and may be accompanied with social, legal, or physical changes. (3) Gender transition procedure.— (A) In general.— The term gender transition procedure means any hormonal or surgical intervention for the purpose of gender transition, including— (i) gonadotropin-releasing hormone (GnRH) agonists or other puberty-blocking or suppressing drugs to stop or delay normal puberty; (ii) testosterone, estrogen, progesterone, or other androgens to an individual at doses that are supraphysiologic to what would normally be produced endogenously in a healthy individual of the same age and sex; (iii) castration; (iv) orchiectomy; (v) scrotoplasty; (vi) implantation of erection or testicular prostheses; (vii) vasectomy; (viii) hysterectomy; (ix) oophorectomy; (x) ovariectomy; (xi) reconstruction of the fixed part of the urethra with or without a metoidioplasty or a phalloplasty; (xii) metoidioplasty; (xiii) penectomy; (xiv) phalloplasty; (xv) vaginoplasty; (xvi) clitoroplasty (xvii) vaginectomy; (xviii) vulvoplasty; (xix) reduction thyrochondroplasty; (xx) chondrolaryngoplasty; (xxi) mastectomy; (xxii) tubal ligation; (xxiii) sterilization; (xxiv) any plastic, cosmetic, or aesthetic surgery that feminizes or masculinizes the facial or other physiological features of an individual; (xxv) any placement of chest implants to create feminine breasts; (xxvi) any placement of fat or artificial implants in the gluteal region; (xxvii) augmentation mammoplasty; (xxviii) liposuction; (xxix) lipofilling; (xxx) voice surgery; (xxxi) hair reconstruction; (xxxii) pectoral implants; and (xxxiii) the removal of any otherwise healthy or non-diseased body part or tissue. (B) Exclusions.— The term gender transition procedure does not include the following when furnished to an individual by a health care provider with the consent of such individual or, if applicable, such individual’s parents or legal guardian: (i) Services to individuals born with a medically verifiable disorder of sex development, including an individual with external sex characteristics that are irresolvably ambiguous, such as an individual born with 46 XX chromosomes with virilization, an individual born with 46 XY chromosomes with undervirilization, or an individual born having both ovarian and testicular tissue. (ii) Services provided when a physician has otherwise diagnosed a disorder of sexual development in which the physician has determined through genetic or biochemical testing that the individual does not have normal sex chromosome structure, sex steroid hormone production, or sex steroid hormone action for a healthy individual of the same sex and age. (iii) The treatment of any infection, injury, disease, or disorder that has been caused by or exacerbated by the performance of gender transition procedures, whether or not the gender transition procedure was performed in accordance with State and Federal law or whether or not funding for the gender transition procedure is permissible under this section. (iv) Any procedure undertaken because the individual suffers from a physical disorder, physical injury, or physical illness (but not mental, behavioral, or emotional distress or a mental, behavioral, or emotional disorder) that would, as certified by a physician, place the individual in imminent danger of death or impairment of major bodily function, unless the procedure is performed. (v) Puberty suppression or blocking prescription drugs for the purpose of normalizing puberty for a minor experiencing precocious puberty. (vi) Male circumcision. (4) Male.— The term male, when used to refer to a natural person, means an individual who naturally has, had, will have, or would have, but for a congenital anomaly, historical accident, or intentional or unintentional disruption, the reproductive system that at some point produces, transports, and utilizes sperm for fertilization. (5) Sex.— The term sex, when referring to an individual’s sex, means to refer to either male or female, as biologically determined..

§ 304

WhereMarkThe Code nowMarkAs the bill would leave it
§ 304. [inserted: Construction relating to separate coverage]
[inserted: Nothing in this chapter shall be construed as prohibiting any individual, entity, or State or locality from purchasing separate coverage for gender transition procedures or health benefits coverage that includes gender transition procedures so long as such coverage is paid for entirely using only funds not authorized or appropriated by Federal law and such coverage shall not be purchased using matching funds required for a federally subsidized program, including a State’s or locality’s contribution of Medicaid matching funds.]

1 U.S.C. § 305 Construction relating to the use of non-Federal funds for health coverage New section

+2 −0Shown
More for 1 U.S.C. § 305
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Title 1, United States Code, is amended by adding at the end the following new chapter:4 Prohibiting taxpayer-funded gender transition procedures 301. Prohibition on funding for gender transition procedures No funds authorized or appropriated by Federal law, and none of the funds in any trust fund to which funds are authorized or appropriated by Federal law, shall be expended for any gender transition procedures. 302. Prohibition on funding for health benefits plans that cover gender transition procedures No funds authorized or appropriated by Federal law, and none of the funds in any trust fund to which funds are authorized or appropriated by Federal law, shall be expended for health benefits coverage that includes coverage of gender transition procedures. 303. Limitation on Federal facilities and employees No health care service furnished— (1) by or in a health care facility owned or operated by the Federal Government; or (2) by any physician or other individual employed by the Federal Government to provide health care services within the scope of the physician’s or individual’s employment, may include gender transition procedures. 304. Construction relating to separate coverage Nothing in this chapter shall be construed as prohibiting any individual, entity, or State or locality from purchasing separate coverage for gender transition procedures or health benefits coverage that includes gender transition procedures so long as such coverage is paid for entirely using only funds not authorized or appropriated by Federal law and such coverage shall not be purchased using matching funds required for a federally subsidized program, including a State’s or locality’s contribution of Medicaid matching funds. 305. Construction relating to the use of non-Federal funds for health coverage Nothing in this chapter shall be construed as restricting the ability of any non-Federal health benefits coverage provider from offering coverage for gender transition procedures, or the ability of a State or locality to contract separately with such a provider for such coverage, so long as only funds not authorized or appropriated by Federal law are used and such coverage shall not be purchased using matching funds required for a federally subsidized program, including a State’s or locality’s contribution of Medicaid matching funds. 306. Construction relating to complications arising from gender transition procedures Nothing in this chapter shall be construed to apply to the treatment of any infection, injury, disease, or disorder that has been caused by or exacerbated by the performance of a gender transition procedure. 307. Definitions For purposes of this chapter: (1) Female.— The term female, when used to refer to a natural person, means an individual who naturally has, had, will have, or would have, but for a congenital anomaly, historical accident, or intentional or unintentional disruption, the reproductive system that at some point produces, transports, and utilizes eggs for fertilization. (2) Gender transition.— The term gender transition means the process in which an individual goes from identifying with or presenting as his or her sex to identifying with or presenting a self-proclaimed identity that does not correspond with or is different from his or her sex, and may be accompanied with social, legal, or physical changes. (3) Gender transition procedure.— (A) In general.— The term gender transition procedure means any hormonal or surgical intervention for the purpose of gender transition, including— (i) gonadotropin-releasing hormone (GnRH) agonists or other puberty-blocking or suppressing drugs to stop or delay normal puberty; (ii) testosterone, estrogen, progesterone, or other androgens to an individual at doses that are supraphysiologic to what would normally be produced endogenously in a healthy individual of the same age and sex; (iii) castration; (iv) orchiectomy; (v) scrotoplasty; (vi) implantation of erection or testicular prostheses; (vii) vasectomy; (viii) hysterectomy; (ix) oophorectomy; (x) ovariectomy; (xi) reconstruction of the fixed part of the urethra with or without a metoidioplasty or a phalloplasty; (xii) metoidioplasty; (xiii) penectomy; (xiv) phalloplasty; (xv) vaginoplasty; (xvi) clitoroplasty (xvii) vaginectomy; (xviii) vulvoplasty; (xix) reduction thyrochondroplasty; (xx) chondrolaryngoplasty; (xxi) mastectomy; (xxii) tubal ligation; (xxiii) sterilization; (xxiv) any plastic, cosmetic, or aesthetic surgery that feminizes or masculinizes the facial or other physiological features of an individual; (xxv) any placement of chest implants to create feminine breasts; (xxvi) any placement of fat or artificial implants in the gluteal region; (xxvii) augmentation mammoplasty; (xxviii) liposuction; (xxix) lipofilling; (xxx) voice surgery; (xxxi) hair reconstruction; (xxxii) pectoral implants; and (xxxiii) the removal of any otherwise healthy or non-diseased body part or tissue. (B) Exclusions.— The term gender transition procedure does not include the following when furnished to an individual by a health care provider with the consent of such individual or, if applicable, such individual’s parents or legal guardian: (i) Services to individuals born with a medically verifiable disorder of sex development, including an individual with external sex characteristics that are irresolvably ambiguous, such as an individual born with 46 XX chromosomes with virilization, an individual born with 46 XY chromosomes with undervirilization, or an individual born having both ovarian and testicular tissue. (ii) Services provided when a physician has otherwise diagnosed a disorder of sexual development in which the physician has determined through genetic or biochemical testing that the individual does not have normal sex chromosome structure, sex steroid hormone production, or sex steroid hormone action for a healthy individual of the same sex and age. (iii) The treatment of any infection, injury, disease, or disorder that has been caused by or exacerbated by the performance of gender transition procedures, whether or not the gender transition procedure was performed in accordance with State and Federal law or whether or not funding for the gender transition procedure is permissible under this section. (iv) Any procedure undertaken because the individual suffers from a physical disorder, physical injury, or physical illness (but not mental, behavioral, or emotional distress or a mental, behavioral, or emotional disorder) that would, as certified by a physician, place the individual in imminent danger of death or impairment of major bodily function, unless the procedure is performed. (v) Puberty suppression or blocking prescription drugs for the purpose of normalizing puberty for a minor experiencing precocious puberty. (vi) Male circumcision. (4) Male.— The term male, when used to refer to a natural person, means an individual who naturally has, had, will have, or would have, but for a congenital anomaly, historical accident, or intentional or unintentional disruption, the reproductive system that at some point produces, transports, and utilizes sperm for fertilization. (5) Sex.— The term sex, when referring to an individual’s sex, means to refer to either male or female, as biologically determined..

§ 305

WhereMarkThe Code nowMarkAs the bill would leave it
§ 305. [inserted: Construction relating to the use of non-Federal funds for health coverage]
[inserted: Nothing in this chapter shall be construed as restricting the ability of any non-Federal health benefits coverage provider from offering coverage for gender transition procedures, or the ability of a State or locality to contract separately with such a provider for such coverage, so long as only funds not authorized or appropriated by Federal law are used and such coverage shall not be purchased using matching funds required for a federally subsidized program, including a State’s or locality’s contribution of Medicaid matching funds.]

1 U.S.C. § 306 Construction relating to complications arising from gender transition procedures New section

+2 −0Shown
More for 1 U.S.C. § 306
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Title 1, United States Code, is amended by adding at the end the following new chapter:4 Prohibiting taxpayer-funded gender transition procedures 301. Prohibition on funding for gender transition procedures No funds authorized or appropriated by Federal law, and none of the funds in any trust fund to which funds are authorized or appropriated by Federal law, shall be expended for any gender transition procedures. 302. Prohibition on funding for health benefits plans that cover gender transition procedures No funds authorized or appropriated by Federal law, and none of the funds in any trust fund to which funds are authorized or appropriated by Federal law, shall be expended for health benefits coverage that includes coverage of gender transition procedures. 303. Limitation on Federal facilities and employees No health care service furnished— (1) by or in a health care facility owned or operated by the Federal Government; or (2) by any physician or other individual employed by the Federal Government to provide health care services within the scope of the physician’s or individual’s employment, may include gender transition procedures. 304. Construction relating to separate coverage Nothing in this chapter shall be construed as prohibiting any individual, entity, or State or locality from purchasing separate coverage for gender transition procedures or health benefits coverage that includes gender transition procedures so long as such coverage is paid for entirely using only funds not authorized or appropriated by Federal law and such coverage shall not be purchased using matching funds required for a federally subsidized program, including a State’s or locality’s contribution of Medicaid matching funds. 305. Construction relating to the use of non-Federal funds for health coverage Nothing in this chapter shall be construed as restricting the ability of any non-Federal health benefits coverage provider from offering coverage for gender transition procedures, or the ability of a State or locality to contract separately with such a provider for such coverage, so long as only funds not authorized or appropriated by Federal law are used and such coverage shall not be purchased using matching funds required for a federally subsidized program, including a State’s or locality’s contribution of Medicaid matching funds. 306. Construction relating to complications arising from gender transition procedures Nothing in this chapter shall be construed to apply to the treatment of any infection, injury, disease, or disorder that has been caused by or exacerbated by the performance of a gender transition procedure. 307. Definitions For purposes of this chapter: (1) Female.— The term female, when used to refer to a natural person, means an individual who naturally has, had, will have, or would have, but for a congenital anomaly, historical accident, or intentional or unintentional disruption, the reproductive system that at some point produces, transports, and utilizes eggs for fertilization. (2) Gender transition.— The term gender transition means the process in which an individual goes from identifying with or presenting as his or her sex to identifying with or presenting a self-proclaimed identity that does not correspond with or is different from his or her sex, and may be accompanied with social, legal, or physical changes. (3) Gender transition procedure.— (A) In general.— The term gender transition procedure means any hormonal or surgical intervention for the purpose of gender transition, including— (i) gonadotropin-releasing hormone (GnRH) agonists or other puberty-blocking or suppressing drugs to stop or delay normal puberty; (ii) testosterone, estrogen, progesterone, or other androgens to an individual at doses that are supraphysiologic to what would normally be produced endogenously in a healthy individual of the same age and sex; (iii) castration; (iv) orchiectomy; (v) scrotoplasty; (vi) implantation of erection or testicular prostheses; (vii) vasectomy; (viii) hysterectomy; (ix) oophorectomy; (x) ovariectomy; (xi) reconstruction of the fixed part of the urethra with or without a metoidioplasty or a phalloplasty; (xii) metoidioplasty; (xiii) penectomy; (xiv) phalloplasty; (xv) vaginoplasty; (xvi) clitoroplasty (xvii) vaginectomy; (xviii) vulvoplasty; (xix) reduction thyrochondroplasty; (xx) chondrolaryngoplasty; (xxi) mastectomy; (xxii) tubal ligation; (xxiii) sterilization; (xxiv) any plastic, cosmetic, or aesthetic surgery that feminizes or masculinizes the facial or other physiological features of an individual; (xxv) any placement of chest implants to create feminine breasts; (xxvi) any placement of fat or artificial implants in the gluteal region; (xxvii) augmentation mammoplasty; (xxviii) liposuction; (xxix) lipofilling; (xxx) voice surgery; (xxxi) hair reconstruction; (xxxii) pectoral implants; and (xxxiii) the removal of any otherwise healthy or non-diseased body part or tissue. (B) Exclusions.— The term gender transition procedure does not include the following when furnished to an individual by a health care provider with the consent of such individual or, if applicable, such individual’s parents or legal guardian: (i) Services to individuals born with a medically verifiable disorder of sex development, including an individual with external sex characteristics that are irresolvably ambiguous, such as an individual born with 46 XX chromosomes with virilization, an individual born with 46 XY chromosomes with undervirilization, or an individual born having both ovarian and testicular tissue. (ii) Services provided when a physician has otherwise diagnosed a disorder of sexual development in which the physician has determined through genetic or biochemical testing that the individual does not have normal sex chromosome structure, sex steroid hormone production, or sex steroid hormone action for a healthy individual of the same sex and age. (iii) The treatment of any infection, injury, disease, or disorder that has been caused by or exacerbated by the performance of gender transition procedures, whether or not the gender transition procedure was performed in accordance with State and Federal law or whether or not funding for the gender transition procedure is permissible under this section. (iv) Any procedure undertaken because the individual suffers from a physical disorder, physical injury, or physical illness (but not mental, behavioral, or emotional distress or a mental, behavioral, or emotional disorder) that would, as certified by a physician, place the individual in imminent danger of death or impairment of major bodily function, unless the procedure is performed. (v) Puberty suppression or blocking prescription drugs for the purpose of normalizing puberty for a minor experiencing precocious puberty. (vi) Male circumcision. (4) Male.— The term male, when used to refer to a natural person, means an individual who naturally has, had, will have, or would have, but for a congenital anomaly, historical accident, or intentional or unintentional disruption, the reproductive system that at some point produces, transports, and utilizes sperm for fertilization. (5) Sex.— The term sex, when referring to an individual’s sex, means to refer to either male or female, as biologically determined..

§ 306

WhereMarkThe Code nowMarkAs the bill would leave it
§ 306. [inserted: Construction relating to complications arising from gender transition procedures]
[inserted: Nothing in this chapter shall be construed to apply to the treatment of any infection, injury, disease, or disorder that has been caused by or exacerbated by the performance of a gender transition procedure.]

1 U.S.C. § 307 Definitions New section

+93 −0Shown
More for 1 U.S.C. § 307
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Title 1, United States Code, is amended by adding at the end the following new chapter:4 Prohibiting taxpayer-funded gender transition procedures 301. Prohibition on funding for gender transition procedures No funds authorized or appropriated by Federal law, and none of the funds in any trust fund to which funds are authorized or appropriated by Federal law, shall be expended for any gender transition procedures. 302. Prohibition on funding for health benefits plans that cover gender transition procedures No funds authorized or appropriated by Federal law, and none of the funds in any trust fund to which funds are authorized or appropriated by Federal law, shall be expended for health benefits coverage that includes coverage of gender transition procedures. 303. Limitation on Federal facilities and employees No health care service furnished— (1) by or in a health care facility owned or operated by the Federal Government; or (2) by any physician or other individual employed by the Federal Government to provide health care services within the scope of the physician’s or individual’s employment, may include gender transition procedures. 304. Construction relating to separate coverage Nothing in this chapter shall be construed as prohibiting any individual, entity, or State or locality from purchasing separate coverage for gender transition procedures or health benefits coverage that includes gender transition procedures so long as such coverage is paid for entirely using only funds not authorized or appropriated by Federal law and such coverage shall not be purchased using matching funds required for a federally subsidized program, including a State’s or locality’s contribution of Medicaid matching funds. 305. Construction relating to the use of non-Federal funds for health coverage Nothing in this chapter shall be construed as restricting the ability of any non-Federal health benefits coverage provider from offering coverage for gender transition procedures, or the ability of a State or locality to contract separately with such a provider for such coverage, so long as only funds not authorized or appropriated by Federal law are used and such coverage shall not be purchased using matching funds required for a federally subsidized program, including a State’s or locality’s contribution of Medicaid matching funds. 306. Construction relating to complications arising from gender transition procedures Nothing in this chapter shall be construed to apply to the treatment of any infection, injury, disease, or disorder that has been caused by or exacerbated by the performance of a gender transition procedure. 307. Definitions For purposes of this chapter: (1) Female.— The term female, when used to refer to a natural person, means an individual who naturally has, had, will have, or would have, but for a congenital anomaly, historical accident, or intentional or unintentional disruption, the reproductive system that at some point produces, transports, and utilizes eggs for fertilization. (2) Gender transition.— The term gender transition means the process in which an individual goes from identifying with or presenting as his or her sex to identifying with or presenting a self-proclaimed identity that does not correspond with or is different from his or her sex, and may be accompanied with social, legal, or physical changes. (3) Gender transition procedure.— (A) In general.— The term gender transition procedure means any hormonal or surgical intervention for the purpose of gender transition, including— (i) gonadotropin-releasing hormone (GnRH) agonists or other puberty-blocking or suppressing drugs to stop or delay normal puberty; (ii) testosterone, estrogen, progesterone, or other androgens to an individual at doses that are supraphysiologic to what would normally be produced endogenously in a healthy individual of the same age and sex; (iii) castration; (iv) orchiectomy; (v) scrotoplasty; (vi) implantation of erection or testicular prostheses; (vii) vasectomy; (viii) hysterectomy; (ix) oophorectomy; (x) ovariectomy; (xi) reconstruction of the fixed part of the urethra with or without a metoidioplasty or a phalloplasty; (xii) metoidioplasty; (xiii) penectomy; (xiv) phalloplasty; (xv) vaginoplasty; (xvi) clitoroplasty (xvii) vaginectomy; (xviii) vulvoplasty; (xix) reduction thyrochondroplasty; (xx) chondrolaryngoplasty; (xxi) mastectomy; (xxii) tubal ligation; (xxiii) sterilization; (xxiv) any plastic, cosmetic, or aesthetic surgery that feminizes or masculinizes the facial or other physiological features of an individual; (xxv) any placement of chest implants to create feminine breasts; (xxvi) any placement of fat or artificial implants in the gluteal region; (xxvii) augmentation mammoplasty; (xxviii) liposuction; (xxix) lipofilling; (xxx) voice surgery; (xxxi) hair reconstruction; (xxxii) pectoral implants; and (xxxiii) the removal of any otherwise healthy or non-diseased body part or tissue. (B) Exclusions.— The term gender transition procedure does not include the following when furnished to an individual by a health care provider with the consent of such individual or, if applicable, such individual’s parents or legal guardian: (i) Services to individuals born with a medically verifiable disorder of sex development, including an individual with external sex characteristics that are irresolvably ambiguous, such as an individual born with 46 XX chromosomes with virilization, an individual born with 46 XY chromosomes with undervirilization, or an individual born having both ovarian and testicular tissue. (ii) Services provided when a physician has otherwise diagnosed a disorder of sexual development in which the physician has determined through genetic or biochemical testing that the individual does not have normal sex chromosome structure, sex steroid hormone production, or sex steroid hormone action for a healthy individual of the same sex and age. (iii) The treatment of any infection, injury, disease, or disorder that has been caused by or exacerbated by the performance of gender transition procedures, whether or not the gender transition procedure was performed in accordance with State and Federal law or whether or not funding for the gender transition procedure is permissible under this section. (iv) Any procedure undertaken because the individual suffers from a physical disorder, physical injury, or physical illness (but not mental, behavioral, or emotional distress or a mental, behavioral, or emotional disorder) that would, as certified by a physician, place the individual in imminent danger of death or impairment of major bodily function, unless the procedure is performed. (v) Puberty suppression or blocking prescription drugs for the purpose of normalizing puberty for a minor experiencing precocious puberty. (vi) Male circumcision. (4) Male.— The term male, when used to refer to a natural person, means an individual who naturally has, had, will have, or would have, but for a congenital anomaly, historical accident, or intentional or unintentional disruption, the reproductive system that at some point produces, transports, and utilizes sperm for fertilization. (5) Sex.— The term sex, when referring to an individual’s sex, means to refer to either male or female, as biologically determined..

§ 307(1)–(5)

WhereMarkThe Code nowMarkAs the bill would leave it
§ 307. [inserted: Definitions]
[inserted: For purposes of this chapter:]
(1)(1) [inserted: Female.—]
[inserted: The term “female”, when used to refer to a natural person, means an individual who naturally has, had, will have, or would have, but for a congenital anomaly, historical accident, or intentional or unintentional disruption, the reproductive system that at some point produces, transports, and utilizes eggs for fertilization.]
(2)(2) [inserted: Gender transition.—]
[inserted: The term “gender transition” means the process in which an individual goes from identifying with or presenting as his or her sex to identifying with or presenting a self-proclaimed identity that does not correspond with or is different from his or her sex, and may be accompanied with social, legal, or physical changes.]
(3)(3) [inserted: Gender transition procedure.—]
(3)(A)(A) [inserted: In general.—]
[inserted: The term “gender transition procedure” means any hormonal or surgical intervention for the purpose of gender transition, including—]
(3)(A)(i)(i) [inserted: ]
[inserted: gonadotropin-releasing hormone (GnRH) agonists or other puberty-blocking or suppressing drugs to stop or delay normal puberty;]
(3)(A)(ii)(ii) [inserted: ]
[inserted: testosterone, estrogen, progesterone, or other androgens to an individual at doses that are supraphysiologic to what would normally be produced endogenously in a healthy individual of the same age and sex;]
(3)(A)(iii)(iii) [inserted: ]
[inserted: castration;]
(3)(A)(iv)(iv) [inserted: ]
[inserted: orchiectomy;]
(3)(A)(v)(v) [inserted: ]
[inserted: scrotoplasty;]
(3)(A)(vi)(vi) [inserted: ]
[inserted: implantation of erection or testicular prostheses;]
(3)(A)(vii)(vii) [inserted: ]
[inserted: vasectomy;]
(3)(A)(viii)(viii) [inserted: ]
[inserted: hysterectomy;]
(3)(A)(ix)(ix) [inserted: ]
[inserted: oophorectomy;]
(3)(A)(x)(x) [inserted: ]
[inserted: ovariectomy;]
(3)(A)(xi)(xi) [inserted: ]
[inserted: reconstruction of the fixed part of the urethra with or without a metoidioplasty or a phalloplasty;]
(3)(A)(xii)(xii) [inserted: ]
[inserted: metoidioplasty;]
(3)(A)(xiii)(xiii) [inserted: ]
[inserted: penectomy;]
(3)(A)(xiv)(xiv) [inserted: ]
[inserted: phalloplasty;]
(3)(A)(xv)(xv) [inserted: ]
[inserted: vaginoplasty;]
(3)(A)(xvi)(xvi) [inserted: ]
[inserted: clitoroplasty]
(3)(A)(xvii)(xvii) [inserted: ]
[inserted: vaginectomy;]
(3)(A)(xviii)(xviii) [inserted: ]
[inserted: vulvoplasty;]
(3)(A)(xix)(xix) [inserted: ]
[inserted: reduction thyrochondroplasty;]
(3)(A)(xx)(xx) [inserted: ]
[inserted: chondrolaryngoplasty;]
(3)(A)(xxi)(xxi) [inserted: ]
[inserted: mastectomy;]
(3)(A)(xxii)(xxii) [inserted: ]
[inserted: tubal ligation;]
(3)(A)(xxiii)(xxiii) [inserted: ]
[inserted: sterilization;]
(3)(A)(xxiv)(xxiv) [inserted: ]
[inserted: any plastic, cosmetic, or aesthetic surgery that feminizes or masculinizes the facial or other physiological features of an individual;]
(3)(A)(xxv)(xxv) [inserted: ]
[inserted: any placement of chest implants to create feminine breasts;]
(3)(A)(xxvi)(xxvi) [inserted: ]
[inserted: any placement of fat or artificial implants in the gluteal region;]
(3)(A)(xxvii)(xxvii) [inserted: ]
[inserted: augmentation mammoplasty;]
(3)(A)(xxviii)(xxviii) [inserted: ]
[inserted: liposuction;]
(3)(A)(xxix)(xxix) [inserted: ]
[inserted: lipofilling;]
(3)(A)(xxx)(xxx) [inserted: ]
[inserted: voice surgery;]
(3)(A)(xxxi)(xxxi) [inserted: ]
[inserted: hair reconstruction;]
(3)(A)(xxxii)(xxxii) [inserted: ]
[inserted: pectoral implants; and]
(3)(A)(xxxiii)(xxxiii) [inserted: ]
[inserted: the removal of any otherwise healthy or non-diseased body part or tissue.]
(3)(B)(B) [inserted: Exclusions.—]
[inserted: The term “gender transition procedure” does not include the following when furnished to an individual by a health care provider with the consent of such individual or, if applicable, such individual’s parents or legal guardian:]
(3)(B)(i)(i) [inserted: ]
[inserted: Services to individuals born with a medically verifiable disorder of sex development, including an individual with external sex characteristics that are irresolvably ambiguous, such as an individual born with 46 XX chromosomes with virilization, an individual born with 46 XY chromosomes with undervirilization, or an individual born having both ovarian and testicular tissue.]
(3)(B)(ii)(ii) [inserted: ]
[inserted: Services provided when a physician has otherwise diagnosed a disorder of sexual development in which the physician has determined through genetic or biochemical testing that the individual does not have normal sex chromosome structure, sex steroid hormone production, or sex steroid hormone action for a healthy individual of the same sex and age.]
(3)(B)(iii)(iii) [inserted: ]
[inserted: The treatment of any infection, injury, disease, or disorder that has been caused by or exacerbated by the performance of gender transition procedures, whether or not the gender transition procedure was performed in accordance with State and Federal law or whether or not funding for the gender transition procedure is permissible under this section.]
(3)(B)(iv)(iv) [inserted: ]
[inserted: Any procedure undertaken because the individual suffers from a physical disorder, physical injury, or physical illness (but not mental, behavioral, or emotional distress or a mental, behavioral, or emotional disorder) that would, as certified by a physician, place the individual in imminent danger of death or impairment of major bodily function, unless the procedure is performed.]
(3)(B)(v)(v) [inserted: ]
[inserted: Puberty suppression or blocking prescription drugs for the purpose of normalizing puberty for a minor experiencing precocious puberty.]
(3)(B)(vi)(vi) [inserted: ]
[inserted: Male circumcision.]
(4)(4) [inserted: Male.—]
[inserted: The term “male”, when used to refer to a natural person, means an individual who naturally has, had, will have, or would have, but for a congenital anomaly, historical accident, or intentional or unintentional disruption, the reproductive system that at some point produces, transports, and utilizes sperm for fertilization.]
(5)(5) [inserted: Sex.—]
[inserted: The term “sex”, when referring to an individual’s sex, means to refer to either male or female, as biologically determined.]

26 U.S.C. § 36B Refundable credit for coverage under a qualified health plan

+6 −1Shown
More for 26 U.S.C. § 36B
Read § 36BOnly this section
2 changes the bill asks for here, 2 carried out
  1. Carried out:

    Subparagraph (A) of section 36B(c)(3) of the Internal Revenue Code of 1986 is amended by inserting before the period at the end the following: or any health plan that includes coverage for gender transition procedures, as defined in section 307 of title 1, United States Code (other than any procedure described in section 306 of such title).

  2. Carried out:

    Paragraph (3) of section 36B(c) of such Code is amended by adding at the end the following new subparagraph:(C) Separate coverage or plan for gender transition procedures allowed.— (i) Option to purchase separate coverage or plan.— Nothing in subparagraph (A) shall be construed as prohibiting any individual from purchasing separate coverage for gender transition procedures described …

§ 36B(c)Definition and rules relating to applicable taxpayers, coverage months, and qualified health plan(3)–(4)

Start of § 36B to (c)(3)(A)(iii) unchanged

WhereMarkThe Code nowMarkAs the bill would leave it
(3)(A)(iii)(I)(I) (I)
on the basis of the relationship of the individual’s expected household income to such a percentage of the poverty line (or such other amount) as is prescribed by the Secretary of Health and Human Services for purposes of such period, andon the basis of the relationship of the individual’s expected household income to such a percentage of the poverty line (or such other amount) as is prescribed by the Secretary of Health and Human Services for purposes of such period, and
(3)(A)(iii)(II)(II) (II)
not in connection with the occurrence of an event or change in circumstances specified by the Secretary of Health and Human Services for such purposes.not in connection with the occurrence of an event or change in circumstances specified by the Secretary of Health and Human Services for such purposes[inserted: or any health plan that includes coverage for gender transition procedures, as defined in section 307 of title 1, United States Code (other than any procedure described in section 306 of such title)].
(3)(B)(B) Grandfathered health plan(B) Grandfathered health plan
The term “grandfathered health plan” has the meaning given such term by section 1251 of the Patient Protection and Affordable Care Act.The term “grandfathered health plan” has the meaning given such term by section 1251 of the Patient Protection and Affordable Care Act.
(3)(C)(C) [inserted: Separate coverage or plan for gender transition procedures allowed.—]
(3)(C)(i)(i) [inserted: Option to purchase separate coverage or plan.—]
[inserted: Nothing in subparagraph (A) shall be construed as prohibiting any individual from purchasing separate coverage for gender transition procedures described in such subparagraph, or a health plan that includes such gender transition procedures, so long as no credit is allowed under this section with respect to the premiums for such coverage or plan.]
(3)(C)(ii)(ii) [inserted: Option to offer coverage or plan.—]
[inserted: Nothing in subparagraph (A) shall restrict any non-Federal health insurance issuer offering a health plan from offering separate coverage for gender transition procedures described in such subparagraph, or a plan that includes such gender transition procedures, so long as premiums for such separate coverage or plan are not paid for with any amount attributable to the credit allowed under this section (or the amount of any advance payment of the credit under section 1412 of the Patient Protection and Affordable Care Act).]
(4)(4) Special rules for qualified small employer health reimbursement arrangements(4) Special rules for qualified small employer health reimbursement arrangements
(4)(A)(A) In general(A) In general
The term “coverage month” shall not include any month with respect to an employee (or any spouse or dependent of such employee) if for such month the employee is provided a qualified small employer health reimbursement arrangement which constitutes affordable coverage.The term “coverage month” shall not include any month with respect to an employee (or any spouse or dependent of such employee) if for such month the employee is provided a qualified small employer health reimbursement arrangement which constitutes affordable coverage.

Rest of § 36B unchanged

26 U.S.C. § 45R Employee health insurance expenses of small employers

+10 −1Shown
More for 26 U.S.C. § 45R
Read § 45ROnly this section
2 changes the bill asks for here, 2 carried out
  1. Carried out:

    by striking Any term and inserting the following:(1) In general.— Any term; and

  2. Carried out:

    by adding at the end the following new paragraph:(2) Exclusion of health plans including coverage for gender transition procedures.— (A) In general.— In this section, the term “qualified health plan” does not include any health plan that includes coverage for gender transition procedures, as defined in section 307 of title 1, …

§ 45R(g)–(i)

Start of § 45R to (g)(2)(C) unchanged

WhereMarkThe Code nowMarkAs the bill would leave it
(g)(3)(3) Contribution arrangement(3) Contribution arrangement
An arrangement shall not fail to meet the requirements of subsection (d)(4) solely because it provides for the offering of insurance outside of an Exchange.An arrangement shall not fail to meet the requirements of subsection (d)(4) solely because it provides for the offering of insurance outside of an Exchange.
(h)(h) Insurance definitions(h) Insurance definitions
(h)(1)(1) [inserted: In general.—]
[inserted: Any term used in this section which is also used in the Public Health Service Act or subtitle A of title I of the Patient Protection and Affordable Care Act shall have the meaning given such term by such Act or subtitle.]
(h)(2)(2) [inserted: Exclusion of health plans including coverage for gender transition procedures.—]
(h)(2)(A)(A) [inserted: In general.—]
[inserted: In this section, the term “qualified health plan” does not include any health plan that includes coverage for gender transition procedures, as defined in section 307 of title 1, United States Code (other than any procedure described in section 306 of such title).]
(h)(2)(B)(B) [inserted: Separate coverage or plan for gender transition procedures allowed.—]
(h)(2)(B)(i)(i) [inserted: Option to purchase separate coverage or plan.—]
[inserted: Nothing in subparagraph (A) shall be construed as prohibiting any employer from purchasing for its employees separate coverage for gender transition procedures described in such subparagraph, or a health plan that includes such gender transition procedures, so long as no credit is allowed under this section with respect to the employer contributions for such coverage or plan.]
(h)(2)(B)(ii)(ii) [inserted: Option to offer coverage or plan.—]
[inserted: Nothing in subparagraph (A) shall restrict any non-Federal health insurance issuer offering a health plan from offering separate coverage for gender transition procedures described in such subparagraph, or a plan that includes such gender transition procedures, so long as such separate coverage or plan is not paid for with any employer contribution eligible for the credit allowed under this section.]
(h)[struck: Any term used in this section which is also used in the Public Health Service Act or subtitle A of title I of the Patient Protection and Affordable Care Act shall have the meaning given such term by such Act or subtitle.]
(i)(i) Regulations(i) Regulations
The Secretary shall prescribe such regulations as may be necessary to carry out the provisions of this section, including regulations to prevent the avoidance of the 2-year limit on the credit period through the use of successor entities and the avoidance of the limitations under subsection (c) through the use of multiple entities.The Secretary shall prescribe such regulations as may be necessary to carry out the provisions of this section, including regulations to prevent the avoidance of the 2-year limit on the credit period through the use of successor entities and the avoidance of the limitations under subsection (c) through the use of multiple entities.

42 U.S.C. § 18054 Multi-State plans

+2 −0Shown
More for 42 U.S.C. § 18054
Read § 18054Only this section
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Section 1334(a) of Public Law 111–148 (42 U.S.C. 18054(a)) is amended by adding at the end the following new paragraph:(8) Coverage consistent with Federal policy regarding gender transition procedures.— In entering into contracts under this subsection, the Director shall ensure that no multi-State qualified health plan offered in an Exchange provides health benefits coverage for which the …

§ 18054(a)–(b)

Start of § 18054 to (a)(5) unchanged

WhereMarkThe Code nowMarkAs the bill would leave it
(a)(6)(6) Assured availability of varied coverage(6) Assured availability of varied coverage
In entering into contracts under this subsection, the Director shall ensure that with respect to multi-State qualified health plans offered in an Exchange, there is at least one such plan that does not provide coverage of services described in section 18023(b)(1)(B)(i) of this title.In entering into contracts under this subsection, the Director shall ensure that with respect to multi-State qualified health plans offered in an Exchange, there is at least one such plan that does not provide coverage of services described in section 18023(b)(1)(B)(i) of this title.
(a)(7)(7) Withdrawal(7) Withdrawal
Approval of a contract under this subsection may be withdrawn by the Director only after notice and opportunity for hearing to the issuer concerned without regard to subchapter II of chapter 5 and chapter 7 of title 5.Approval of a contract under this subsection may be withdrawn by the Director only after notice and opportunity for hearing to the issuer concerned without regard to subchapter II of chapter 5 and chapter 7 of title 5.
(a)(8)(8) [inserted: Coverage consistent with Federal policy regarding gender transition procedures.—]
[inserted: In entering into contracts under this subsection, the Director shall ensure that no multi-State qualified health plan offered in an Exchange provides health benefits coverage for which the expenditure of Federal funds is prohibited under chapter 4 of title 1, United States Code.]
(b)(b) Eligibility(b) Eligibility
A health insurance issuer shall be eligible to enter into a contract under subsection (a)(1) if such issuer—A health insurance issuer shall be eligible to enter into a contract under subsection (a)(1) if such issuer—
(b)(1)(1) (1)
agrees to offer a multi-State qualified health plan that meets the requirements of subsection (c) in each Exchange in each State;agrees to offer a multi-State qualified health plan that meets the requirements of subsection (c) in each Exchange in each State;

Rest of § 18054 unchanged

Step through the changes